The S&P 500 index’s three-week rebound may be running out of steam as a delay in a promising Covid-19 vaccine trial gnaws at investors’ sentiment.
The S&P 500 index’s three-week rebound may be running out of steam as a delay in a promising Covid-19 vaccine trial gnaws at investors’ sentiment.